medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2016, Número 619

<< Anterior Siguiente >>

Rev Med Cos Cen 2016; 73 (619)


Síndrome de pseudotumor cerebral

Cruz AO, Salazar BBV

Idioma: Español
Referencias bibliográficas: 32
Paginas: 409-417
Archivo PDF: 342.92 Kb.


RESUMEN

El síndrome de pseudotumor cerebral (SPTC) se manifiesta como una entidad caracterizada por cefalea, alteraciones en los campos visuales, papiledema y aumento de la presión de apertura de liquido cefalorraquídeo (LCR) sin evidencia de proceso expansivo intracraneal. Puede ser primario también conocido como hipertensión intracraneal idiopática o secundario a alguna causa identificable. Es una patología casi exclusiva de mujeres obesas en edad fértil. Se han propuesto nuevos criterios diagnósticos para la población adulta y pediátrica debido a un mayor conocimiento de las alteraciones radiológicas asociadas y una mejor comprensión de la enfermedad. El objetivo principal del tratamiento es la conservación y restauración de la visión.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ahmed R, Friedman DI, Halmagyi GM. Stenting of the transverse sinuses in idiopathic intracranial hypertension. J Neuroophthalmol 2011;31:374-380.

  2. Barness LA, Opitz JM and Gilbert- Barness E. Obesity: Genetic, molecular, and environmental aspects. Am J Med Genet A 2007;143:3016–3034.

  3. Bateman GA, Stevens SA, Stimpson J. A mathematical model of idiopathic intracranial hypertension incorporating increased arterial inflow and variable venous outflow collapsibility. J Neurosurg 2009; 110:446-456.

  4. Bidot S, Bruce BB, Saindane AM et al. Asymmetric papilledemma in idiopathic intracranial hypertension. J Neuroophthalmol 2014;0:1 – 6.

  5. Corbett JJ, Thompson HS. The rational management of idiopathic intracranial hypertension. Archives of Neurology 1989;46:1049–1051.

  6. Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg 1973;106:492- 513

  7. Dave S, Longmuir R, Shah VA, et al. Intracranial hypertension in systemic lupus erythematosus. Semin Ophthalmol 2008;23:127–133.

  8. Fridley J, Foroozan R, Sherman V, et al. Bariatric surgery for the treatment of idiopathic intracranial hypertension: a case – control study. Neurology 2011;76:1564 – 7

  9. Friedman DI, Gordon LK, Egan RA, et al. Doxycycline and intracranial hypertension. Neurology 2004; 62: 2297–2299.

  10. Friedman DI, Ingram P, Rogers MA. Low tyramine diet in the treatment of idiopathic intracranial hypertension. A pilot study. Neurology 1998; 50: A5.

  11. Friedman DI, Liu G, Digre KB. Diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 2013;81(13):1159 – 1165.

  12. Giuseffi V, Wall M, Spiegel PZ, et al. Symptoms and disease associations in idio- pathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991;41:239–244.

  13. González-Hernández A, Fabre-Pi O, Diaz-Nicolás S, López- Fernández JC, Lopez-Veloso C, Jiménez- Mateos A. Cefalea en la hipertensión intracraneal idiopática. Rev Neurol. 2009;49:13-17

  14. Koerner JC, Friedman DI. Inpatient and emergency service utilization in patients with idiopathic intracranial hypertension. J Neuroophthalmol 2014;34:229 – 232.

  15. Lepore FE. Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology. 1992;42:676–678

  16. Lindvall-Axelsson M, Nilsson C, Owman C, et al. Involvement of 5-HT1C receptors in the production of CSF from the choroid plexus. In: Seylaz JM, MacKenzie ET, editors. Neurotransmission and cerebrovascular function I. Amsterdam: Elsevier; 1989. p. 237- 240.

  17. Meador KJ, Swift TR. Tinnitus from intracranial hypertension. Neurology 1984;34:1258–1261.

  18. Menger RP, Connor DE Jr, Thakur JD et al. A comparison of lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension: an analysis of economic impact and complications using the Nationwide Inpatient Sample. Neurosurg Focus 2014 Nov; 37(5): E4

  19. Moreau A, Lao KC, Farris BK. Optic nerve sheath decompression: a surgical technique with minimal operative complications. J Neuroophthalmol 2014;34(1):34-38

  20. Puffer RC, Wessam M, Lanzino G. Venous sinus stenting for idiopathic intracranial hypertension: a review of literature. J Neurointervent Surg 2013;5:483 – 486.

  21. Radhakrishanan K, Ahlskog JE, Cross SA, et al. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976-1990. Arch Neurol 1993;50(1):78–80.

  22. Rosenfeld E, Dotan G, Kimchi T. Spontaneous cerebrospinal fluid otorrea and rinorrhea in idiopathic intracranial hypertension patients. J Neuroophthalmol 2013;33:113 – 116.

  23. Sadun AA, Currie J, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol1984;16:489–494.

  24. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treartment in a case series. J Child Neurol 1994;9 (2):30 – 134.

  25. Stienen A, Weinzierl M, Ludolph A, et al. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol 2008;15:1416-1418

  26. Teleb MS, Cziep ME, Lazzaro MA, Gheith A, Asif K, Remler B. et al. Idiopathic Intracranial Hypertension. A Systematic Analysis of Transverse Sinus Stenting. Interv Neurol. 2013;2:132 – 143

  27. Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology 2007;68(3):229 – 232.

  28. The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effects of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss, the idiopathic intracranial hypertension treatment trial (IIHTT). JAMA 2014;311(16):1641 – 1651.

  29. Thurtell MJ, Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr Treat Options Neurol 2013;15 (1):1 – 12.

  30. Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114:155–80.

  31. Warner JEA, Bernstein PS, Yemelyanov A, et al. Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension. Ann Neurol 2002;52: 647–650

  32. Wong R, Madill SA, Pandey P, Riordan-Eva P. Idiopathic intracranial hypertension: the association between weight loss and the requirement for systemic treatment. BMC Ophthalmol. 2007;7:15.




2020     |     www.medigraphic.com